ulcerative-colitis

Documents about ulcerative-colitis

• Expanded Access to Upadacitinib#825033ClinicalTrials.gov
• Virtual Versus Dye-based Chromoendoscopy in Inflammatory Bowel Disease Surveillance Colonoscopy#839750ClinicalTrials.gov
• Use of Psychologist-administered Cognitive Behavioral Therapy (CBT) or Self-administered CBT for the Treatment of Anxiety and/or Depression in Inflammatory Bowel Disease (IBD)#850079ClinicalTrials.gov
• Developing a Self-Management Intervention to Improve Health Outcomes for Patients With Inflammatory Bowel Disease#870841ClinicalTrials.gov
• Elemental Diet for Treatment of Inflammatory Bowel Disease in Patients With Chronic Granulomatous Disease#871048ClinicalTrials.gov
• An Explanatory Factors Analysis of Inflammatory Bowel Diseases(IBD's) Management Costs for Adults Patients Treated by Biotherapy and Followed at Nancy University Hospital#877118ClinicalTrials.gov
• Clinical Study of Targeting CD7 CAR-T Cells in the Treatment of Autoimmune Diseases#1010625ClinicalTrials.gov
• Acceptability, Adherence, and Impact on the Bioavailability of Iron and Zinc of the Dietary Supplements Goodphyte IB Defense and Goodphyte Immunity in Adults With Chronic Diseases.#332851ClinicalTrials.gov
• Chronic Inflammatory Disease, Lifestyle and Treatment Response#812978ClinicalTrials.gov
• A First Time in Human Study to Evaluate the Safety and Tolerability of GSK4381406 in Healthy Participants#967961ClinicalTrials.gov
• Prospective Evaluation of Flare Detection in IBD With Digital Biomarkers: Bring Your Own Device Study#827101ClinicalTrials.gov
• BCMA-CD19 cCAR T for the Treatment of Refractory Inflammatory Bowel Disease (IBD)#845504ClinicalTrials.gov
• Real World Data on Vedolizumab Concentration and Outcomes in Inflammatory Bowel Disease (IBD) Patients Switching From Intravenous (IV) to Subcutaneous (SC) Vedolizumab in University Hospital Center Osijek#869942ClinicalTrials.gov
• A Phase 2 Clinical Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of HRS-7085 Tablets in Patients With Inflammatory Bowel Disease#895017ClinicalTrials.gov
• Stress and Psychological Adjustment in Chronic Illness: An Interpretative Phenomenological Analysis of Early Ulcerative Colitis: Themes and Excerepts,#263830UK Data Service OAI-PMH Repository (Production)
• Chronic Inflammatory Disease, Lifestyle and Risk of Disease#802181ClinicalTrials.gov
• The Risk of Venous Thromboembolism in Systemic Inflammatory Disorders: a United Kingdom (UK) Matched Cohort Study#807802ClinicalTrials.gov
• Influence of Aerobic Exercise Training (AET) on Inflammatory Bowel Disease (IBD) in Children and Adolescents#1009061ClinicalTrials.gov
• Chinese Spondyloarthritis Inception Cohort (CESPIC)#810780ClinicalTrials.gov
• The Epidemiology, Management, and the Associated Burden of Related Conditions in Alopecia Areata#887633ClinicalTrials.gov
• An Assessment of Goal-Directed Intraoperative Fluid Management in Hand Assisted Laparoscopic Colectomy#834742ClinicalTrials.gov
• Budget impact analysis of the subcutaneous infliximab (CT-P13 SC) for treating inflammatory bowel disease in the Big-5 European (E5) countries#923136IRIS
• Initial Experience With a Novel Single-Balloon Enteroscopy System in Children With IBD#980131ClinicalTrials.gov
• Use of biosimilars in inflammatory bowel disease: A position update of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD)#250617IRIS
• The burden of anemia related to inflammatory bowel disease in China: Epidemic trends, subtype differences and driving factors#676367Europe PMC
• The Correlation of a D-dimer Testing Protocol With Venous Thromboembolism in Surgical Colorectal Patients#804791ClinicalTrials.gov
• Partial Enteral Nutrition to Prevent Weight Loss and Sarcopenia in IBD Patients at Nutritional Risk - SIMBA#834317ClinicalTrials.gov
• Study to Evaluate the Epidemiology and the Characteristics "Omics" in Patients Recently Diagnosed of Inflammatory Bowel Disease in Spain#810446ClinicalTrials.gov
• Childhood-onset Inflammatory Bowel Disease with focus on Immunoreactivity in Blood and Associated Conditions affecting the Oral Cavity and the Skeleton#1053296GUPEA
• The Mannose Receptor (CD206) Identifies a Population of Colonic Macrophages in Health and Inflammatory Bowel Disease#413212Scholar Commons
• Study of Efficacy and Adherence to Subcutaneous vs. Intravenous Vedolizumab in Patients With Inflammatory Bowel Disease Using a Novel Remote MONITORing Intervention#886855ClinicalTrials.gov
• Precision Diagnostics of Functional and Organic Intestinal Pathology Based on Cellular and Molecular Profiling#890774ClinicalTrials.gov
• IBD Biomarker Discovery and Validation Platform#969561ClinicalTrials.gov
• Atrophy and neoplastic transformation of the ileal pouch mucosa in patients with ulcerative colitis and primary sclerosing cholangitis - A case control study#644894Lund University Publications
• Comparing Diagnostic Accuracy of High-end Intestinal Ultrasound Versus Mid-end Ultrasound With Tandem Ileo-colonoscopy in Inflammatory Bowel Disease : a Paired, Validating Confirmatory Study#806121ClinicalTrials.gov
• Efficacy and Mechanism of Fecal Microbiota Transplantation of the Bai Ethnicity in the Treatment of UC#895227ClinicalTrials.gov
• Table 1_Health-Related quality of life in Russian children with inflammatory bowel disease is comparable across disease types and treatment modalities.docx#408504Figshare
• Data and code for: Integrating machine learning, molecular docking, and 100-ns molecular dynamics simulations to identify SLC6A4 and DPP4 as direct targets of koumine in ulcerative colitis#353647Figshare
• SAPHIR : Assessment of Predictive Factors for Persistence of Treatment After Initiation of Adalimumab With a Biosimilar (Adalimumab Fresenius KaBI or Substitution of Reference Adalimumab With the Fresenius Kabi Adalimumab Biosimilar in Patients With Chronic Inflammatory Diseases#849548ClinicalTrials.gov
• A Biospecimen Collection Study to Identify the Targets of Disease-Reactive T Cells in Patients With Autoimmune Disease#835171ClinicalTrials.gov
• Impact of a Human Origin Heat Inactivated Probiotic-Lactobacillus Paracasei D3.5 (LpD3.5) as Dietary Supplement on Gut Mucin and Intestinal Permeability in Adults With IBD#863435ClinicalTrials.gov
• Exploration of the Activity of DNA Located Outside of Cellular Nucleus to Amplify Inflammation in Inflammatory Bowel Disease in Children Through Biological Pathway Cyclic GMP-AMP Synthase (cGAS) - Stimulator of Interferon Genes (STING)#982766ClinicalTrials.gov
• From tissue to blood: an integrated multi-omics signature identifies fibrogenesis and neutrophil activation as key drivers of ulcerative colitis severity / Enrique Ozcariz, Marek Ostaszewski, Oxana Lopata, Lucia Ciglar, Andrew Yung Fong Li Yim, Maarten Pruijt, Xinhui Wang, Gabriel Alexander Vignolle, Florian Tran, Venkata P. Satagopam, Geert R. D’Haens, Stefan Schreiber, Philip Rosenstiel, Christa Nöhammer, Klemens Vierlinger#814188Deutsche Nationalbibliothek